Effect of amphotericin B on the production of tumor necrosis factor-α and interleukin-8 and activation of signaling molecule p38MAPK in human THP-1 cells
Wenxia Ye, Leilei Du, Zhimin Duan, Caixia Liu, Min Li, Yu Gao
Abstract
Wenxia Ye, Leilei Du, Zhimin Duan, Caixia Liu, Min Li, Yu Gao
Abstract
Objective To evaluate the effect of amphotericin B on the production of tumor necrosis factor-α (TNF-α) and interleukin-8 (IL-8) and activation of p38 mitogen-activated protein kinases (p38MAPK) in a human acute monocytic leukemia cell line (THP-1) . Methods Cultured THP-1 cells were divided into several groups: blank control group receiving no treatment, amphotericin B groups treated with 2, 4 and 8 mg/L amphotericin B separately, positive control group treated with 100 μg/L β-glucosan or 100 mg/L lipopolysaccharide. Real-time fluorescence-based quantitative PCR was performed to determine the mRNA expression of TNF-α and IL-8 after the THP-1 cells were treated with different stimuli for some durations. Enzyme-linked immunosorbent assay (ELISA) was conducted to detect the level of TNF-α in the culture supernatant of THP-1 cells after 24-hour treatment with 8 mg/L amphotericin B, and Western blot analysis to measure the levels of p38MAPK and phosphorylated p38MAPK after 30-minute treatment with 8 mg/L amphotericin B. Results After 6-hour treatment with 2, 4 and 8 mg/L amphotericin B separately, the mRNA levels of TNF-α in THP-1 cells (7.55 ± 1.17, 19.47 ± 2.91, 57.22 ± 0.65) and IL-8 (2.98 ± 0.04, 5.22 ± 1.35, 11.82 ± 1.66) were all significantly higher than those in the blank control group (TNF-α: 1.00 ± 0.07, P < 0.01, 0.001, 0.001 respectively; IL-8: 1.01 ± 0.23, P < 0.01, 0.001, 0.001 respectively) . After the treatment with 8 mg/L amphotericin B for 1, 3, 6 hours, the mRNA levels of TNF-α (8.61 ± 0.30, 10.75 ± 0.08, 56.98 ± 2.43) and IL-8 (2.63 ± 0.28, 5.35 ± 0.98, 11.73 ± 1.18) in THP-1 cells were all significantly higher than those in the blank control group (TNF-α: 1.18 ± 0.17, P < 0.05, 0.01, 0.001; IL-8: 1.23 ± 0.11, P < 0.05, 0.01, 0.001) . After 24-hour treatment with 8 mg/L amphotericin B, the level of TNF-α in the culture supernatant of THP-1 cells was significantly higher than that in the blank control group (4 039.06 ± 223.87 ng/L vs. 96.31 ± 0.26 ng/L, P < 0.001) . Conclusion Amphotericin B can promote the p38MAPK phosphorylation and increase the levels of TNF-α and IL-8 in human THP-1 cells in vitro, suggesting its immunomodulatory effects. Key words: Amphotericin B; Tumor necrosis factor-alpha; Interleukin-8; p38 Mitogen-activated protein kinases; THP-1 monocytes
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the effect of amphotericin B on the production of tumor necrosis factor-α (TNF-α) and interleukin-8 (IL-8) and activation of p38 mitogen-activated protein kinases (p38MAPK) in a human acute monocytic leukemia cell line (THP-1) . Methods Cultured THP-1 cells were divided into several groups: blank control group receiving no treatment, amphotericin B groups treated with 2, 4 and 8 mg/L amphotericin B separately, positive control group treated with 100 μg/L β-glucosan or 100 mg/L lipopolysaccharide. Real-time fluorescence-based quantitative PCR was performed to determine the mRNA expression of TNF-α and IL-8 after the THP-1 cells were treated with different stimuli for some durations. Enzyme-linked immunosorbent assay (ELISA) was conducted to detect the level of TNF-α in the culture supernatant of THP-1 cells after 24-hour treatment with 8 mg/L amphotericin B, and Western blot analysis to measure the levels of p38MAPK and phosphorylated p38MAPK after 30-minute treatment with 8 mg/L amphotericin B. Results After 6-hour treatment with 2, 4 and 8 mg/L amphotericin B separately, the mRNA levels of TNF-α in THP-1 cells (7.55 ± 1.17, 19.47 ± 2.91, 57.22 ± 0.65) and IL-8 (2.98 ± 0.04, 5.22 ± 1.35, 11.82 ± 1.66) were all significantly higher than those in the blank control group (TNF-α: 1.00 ± 0.07, P < 0.01, 0.001, 0.001 respectively; IL-8: 1.01 ± 0.23, P < 0.01, 0.001, 0.001 respectively) . After the treatment with 8 mg/L amphotericin B for 1, 3, 6 hours, the mRNA levels of TNF-α (8.61 ± 0.30, 10.75 ± 0.08, 56.98 ± 2.43) and IL-8 (2.63 ± 0.28, 5.35 ± 0.98, 11.73 ± 1.18) in THP-1 cells were all significantly higher than those in the blank control group (TNF-α: 1.18 ± 0.17, P < 0.05, 0.01, 0.001; IL-8: 1.23 ± 0.11, P < 0.05, 0.01, 0.001) . After 24-hour treatment with 8 mg/L amphotericin B, the level of TNF-α in the culture supernatant of THP-1 cells was significantly higher than that in the blank control group (4 039.06 ± 223.87 ng/L vs. 96.31 ± 0.26 ng/L, P < 0.001) . Conclusion Amphotericin B can promote the p38MAPK phosphorylation and increase the levels of TNF-α and IL-8 in human THP-1 cells in vitro, suggesting its immunomodulatory effects. Key words: Amphotericin B; Tumor necrosis factor-alpha; Interleukin-8; p38 Mitogen-activated protein kinases; THP-1 monocytes
Key concepts: Amphotericin B, Tumor necrosis factor alpha, THP1 cell line, Western blot, Lipopolysaccharide, Molecular biology, Cytokine, Interleukin